SOPHiA GENETICS (SOPH) Operating Expenses (2020 - 2025)

SOPHiA GENETICS has disclosed Operating Expenses across 6 years of filings, most recently posting -$23.3 million for Q4 2025.

• Operating Expenses for Q4 2025 came in at -$23.3 million, down 6.89% year-over-year; the trailing twelve-month figure through Dec 2025 was -$86.8 million (down 6.71% YoY), and the FY2025 annual result was -$86.8 million, down 6.71% from the prior year.
• Operating Expenses came in at -$23.3 million for Q4 2025 at SOPHiA GENETICS, down from -$22.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$14.6 million in Q2 2021 to a low of -$23.9 million in Q1 2022.
• The 5-year median for Operating Expenses is -$21.8 million (2023), against an average of -$20.9 million.
• Across the five-year window, Operating Expenses soared 99.8% in 2021 and slumped 62.14% in 2022, its largest moves.
• SOPHiA GENETICS's Operating Expenses stood at -$19.3 million in 2021, then dropped by 7.26% to -$20.7 million in 2022, then slipped by 11.14% to -$23.0 million in 2023, then climbed by 5.3% to -$21.8 million in 2024, then slipped by 6.89% to -$23.3 million in 2025.
• The last three Operating Expenses figures came in at -$23.3 million (Q4 2025), -$22.0 million (Q3 2025), and -$20.8 million (Q2 2025), per Business Quant data.